AstraZeneca’s Covid-19 vaccines made by Thailand's Siam Bioscience pass quality testing in Europe and US


BANGKOK (The Nation/ANN): AstraZeneca announced on Sunday (May 9) that the samples from test batches of the Covid-19 vaccine made by Siam Bioscience had passed the quality testing at AstraZeneca’s designated laboratories in Europe and in the US.

James Teague, Country President, AstraZeneca (Thailand) Ltd., said: “We have seen a series of significant and promising progress in AstraZeneca’s Covid-19 vaccine development in Thailand during the past weeks

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Aseanplus News

Indian singer Zubeen Garg swam without life vest, drowned near Lazarus Island: Coroner’s court
Bangkok wakes to toxic air choking central business districts
Taiwanese comedian Peng Chia Chia, 69, sells fruits at midnight to clear millions in debt
Philippine landfill collapse: Cebu City placed under state of calamity as death toll climbs to 13
Death toll rises to 19 in Thailand with 80 injured after crane collapses on train, police say
‘Are You Dead?’: Viral safety app reflects quiet anxiety of living alone in China
Oil prices pause gains as Venezuela shipments resume but Iran concerns loom
Asian stocks inch higher, fragile yen spurs intervention worries�
FBM KLCI struggles to extend gains amid profit-taking pressure
Senior Armed Forces officer arrested in graft probe

Others Also Read